Considering Biological and Biosimilar Medicines to Treat Rheumatic Diseases – Making the Right Call – Certificate of Completion

Description

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint swelling, joint tenderness and destruction of synovial joints. The primary goal in treating patients with RA is to maximise long-term quality of life. In recent years, treat-to-target recommendations have been formulated for the management of RA. These targets include either remission (the absence of symptoms or signs of inflammatory disease activity) or low-level disease activity.